Non Inferiority KawasakI Trial With Anakinra

NCT06697431 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Kawasaki Disease
Anakinra

Interventions

DRUG: Anakinra
DRUG: Intravenous Immunoglobulins, Human

Sponsor

Meyer Children's Hospital IRCCS

Collaborators

[object Object]
[object Object]